Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study Cover

.blurhash-client-img { display: none !important; }

Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study

EABR. Experimental and Applied Biomedical Research

Volume 22 (2021): Issue 4 (December 2021)

By: Ravinder Singh, Harbir Kaur Rao, Anil Sharma, Thakur Gurjeet Singh, Abhimanyu Parashar, Randhir Singh and Balraj Saini

Open Access

|Feb 2022

Authors

Ravinder Singh

Chitkara College of Pharmacy, Chitkara University, Punjab, India

Harbir Kaur Rao

Gian Sagar Medical College and Hospital, Patiala

Anil Sharma

Amil Pharmaceuticals, New Delhi

Thakur Gurjeet Singh

gurjeet.singh@chitkara.edu.in

Chitkara College of Pharmacy, Chitkara University, Punjab, India

Abhimanyu Parashar

Chitkara College of Pharmacy, Chitkara University, Punjab, India

Randhir Singh

MM College of Pharmacy, Maharishi Markandeshwar University Mullana, Ambala, India

Balraj Saini

Chitkara College of Pharmacy, Chitkara University, Punjab, India

DOI: https://doi.org/10.2478/sjecr-2021-0057 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454

Journal RSS Feed

Language: English

Page range: 325 - 332

Submitted on: Oct 5, 2020

|

Accepted on: Mar 6, 2021

|

Published on: Feb 2, 2022

Published by: University of Kragujevac, Faculty of Medical Sciences

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

diabetes mellitus,

blood glucose regulator-34,

DPP-4 inhibitors,

Related subjects:

Clinical medicine,

Clinical medicine, other

© 2022 Ravinder Singh, Harbir Kaur Rao, Anil Sharma, Thakur Gurjeet Singh, Abhimanyu Parashar, Randhir Singh, Balraj Saini, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 22 (2021): Issue 4 (December 2021)Next article